[ad_1]
Riverwater Companions, an funding administration firm, launched its “Micro Alternatives Technique” Q3 2025 investor letter. The technique reported optimistic returns within the quarter however lagged its benchmark because it didn’t hold tempo with the sturdy rally. The technique continues to concentrate on high quality corporations within the risky setting. As well as, you may verify the fund’s high 5 holdings to find out its finest picks for 2025.
In its third-quarter 2025 investor letter, Riverwater Companions Micro Alternatives Technique highlighted shares similar to IRADIMED CORPORATION (NASDAQ:IRMD). Headquartered in Winter Springs, Florida, IRADIMED CORPORATION (NASDAQ:IRMD) is a magnetic resonance imaging (MRI) suitable medical machine producer. The one-month return for IRADIMED CORPORATION (NASDAQ:IRMD) was 13.54%, and its shares gained 84.62% over the past 52 weeks. On December 15, 2025, IRADIMED CORPORATION (NASDAQ:IRMD) inventory closed at $97.02 per share, with a market capitalization of $1.244 billion.
Riverwater Companions Micro Alternatives Technique acknowledged the next concerning IRADIMED CORPORATION (NASDAQ:IRMD) in its third quarter 2025 investor letter:
“Our Healthcare holdings delivered strong contributions, led by IRADIMED CORPORATION (NASDAQ:IRMD). IRMD’s MRI-compatible units have gained market share, and the corporate’s sturdy recurring income mannequin and wonderful returns on invested capital make it a perfect match for our quality-focused method. We proceed to view medical know-how as a compelling subsector providing combining long-term progress alternatives with affordable valuations.”
IRADIMED CORPORATION (NASDAQ:IRMD) just isn’t on our checklist of 30 Most Standard Shares Amongst Hedge Funds. As per our database, 14 hedge fund portfolios held IRADIMED CORPORATION (NASDAQ:IRMD) on the finish of the third quarter, which was 13 within the earlier quarter. In Q3 2025, IRADIMED CORPORATION (NASDAQ:IRMD) reported report income of $21.2 million, marking a rise of 16% from Q3 2024. Whereas we acknowledge the potential of IRADIMED CORPORATION (NASDAQ:IRMD) as an funding, we consider sure AI shares provide higher upside potential and carry much less draw back danger. For those who’re in search of a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
In one other article, we lined IRADIMED CORPORATION (NASDAQ:IRMD) and shared the checklist of finest small-cap shares with enormous potential in response to Reddit as market seems to be past AI commerce. As well as, please take a look at our hedge fund investor letters Q3 2025 web page for extra investor letters from hedge funds and different main traders.
[ad_2]
